Celldex Therapeutics, Inc. (CLDX) Net income 2016–2025
Celldex Therapeutics, Inc. (CLDX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$258.8MFY2025 · since FY2016: -$128.5M → -$258.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$258.8M | -63.9% |
| FY2024 | -$157.9M | -11.6% |
| FY2023 | -$141.4M | -25.9% |
| FY2022 | -$112.3M | -59.3% |
| FY2021 | -$70.5M | -18.0% |
| FY2020 | -$59.8M | -17.5% |
| FY2019 | -$50.9M | +66.3% |
| FY2018 | -$151.2M | -62.5% |
| FY2017 | -$93.0M | +27.6% |
| FY2016 | -$128.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice